Unjha Formulations shareholders approve FY26 results, appoint Krutiben Patel as MD
Unjha Formulations Limited concluded its 32nd AGM on August 14, 2026, with shareholders approving the FY26 audited financials. Key governance changes included the reappointment of Chairperson Jashodaben S. Patel and the new appointment of Krutiben M. Patel as Managing Director for three years. Related party transactions for FY27 were also approved.

*this image is generated using AI for illustrative purposes only.
Unjha Formulations Limited ( Unjha Formulations ) shareholders approved the company’s audited financial statements for the fiscal year ended March 31, 2026, during its 32nd Annual General Meeting (AGM) held on August 14, 2026. The meeting, convened at the company’s registered office in Sidhpur, Gujarat, also resulted in the appointment of Krutiben M. Patel as Managing Director for a three-year term.
The AGM was declared open by Company Secretary Khushboo N. Patel after confirming the presence of quorum. All directors attended the proceedings. Ajay Parikh & Associates served as the secretarial auditors and scrutinizers for the votes cast via remote e-voting and during the physical meeting.
Key Resolutions Passed
The shareholders transacted the following businesses through remote e-voting and e-voting at the venue, in compliance with the Companies Act, 2013 and SEBI regulations:
Ordinary Resolutions:
- Adoption of the audited financial statements for the year ended March 31, 2026.
- Appointment of Jashodaben S. Patel (DIN 05201715) as a director in place of her retirement by rotation.
Special Resolutions:
- Approval of related party transactions for the fiscal year 2026-27.
- Appointment of Krutiben M. Patel as Managing Director for a term of three years.
Management Commentary
Jashodaben S. Patel, Chairperson, delivered the statement on the affairs of the company. Krutiben Patel, Managing Director, addressed questions raised by members regarding the resolutions. The voting process continued for an additional 15 minutes on the CDSL platform to allow remaining members to cast their votes. The meeting concluded at 11:40 am.
Detailed voting results, as required under Regulation 44(3) of the SEBI Listing Regulations, were submitted separately to the exchanges.
Historical Stock Returns for Unjha Formulations
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.70% | +17.40% | +14.99% | +20.22% | +13.54% | +167.94% |
How is the appointment of Krutiben M. Patel as Managing Director expected to influence Unjha Formulations' strategic growth and operational efficiency over the next three years?
What specific growth initiatives or capital expenditure plans are implied by the approval of related party transactions for the fiscal year 2026-27?
Given the adoption of financials for FY 2026, what are the management's projected revenue and margin targets for the upcoming fiscal year amidst current pharmaceutical market dynamics?


































